[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $pvla

Palvella Therapeutics (PVLA) sees significant social media buzz with a XXX% increase in posts. Analysts maintain positive outlooks with multiple buy ratings and price targets, while some critical themes emerge around profit-taking ahead of key catalysts.

### About $pvla
Palvella Therapeutics, Inc. is a biotechnology company focused on developing treatments.  

### Insights
- $pvla posts created is up XXX% from the previous month.

### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$pvla/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$pvla/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXXX -XX%  
X Month: XXXXXXX +211%  
X Months: XXXXXXX +190%  
1-Year High: XXXXXX on 2025-05-14  
1-Year Low: X on 2025-01-25  

Engagements by network (24h):
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$pvla/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$pvla/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX +259%  
X Months: XXXXX +2,020%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2024-12-14  

Mentions by network (24h):
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$pvla/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$pvla/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $pvla in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XX +196%  
X Months: XXXXX +3,258%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2024-12-14  

The most influential creators that mention $pvla in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)         | X    | XXXXXX    | X     | XXXXX       |
| [@SteveDJacobs](/creator/twitter/SteveDJacobs)     | X    | XXXXX     | X     | XXX         |
| [@Barryman833058](/creator/twitter/Barryman833058) | X    | XXX       | X     | XX          |
| [@notreload_ai](/creator/twitter/notreload_ai)     | X    | XXXXX     | X     | XX          |
| [@OpenOutcrier](/creator/twitter/OpenOutcrier)     | X    | XXXXXX    | X     | XX          |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)   | X    | XXXXX     | X     | XX          |
| [@Giulio01839130](/creator/twitter/Giulio01839130) | X    | XXX       | X     | X           |

[View More](/list/creators/$pvla/100)
  
  
### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$pvla/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$pvla/time-series/sentiment.tsv)  
Current Value: XXX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% no change  
X Months: XXX% +50%  
1-Year High: XXX% on 2024-12-27  
1-Year Low: XX% on 2024-12-26  

Most Supportive Themes:
- Clinical Trial Progress: (50%) Mentions of upcoming Phase X and Phase X clinical trial readouts for PVLA and other biotech companies.
- Analyst Upgrades and Price Targets: (25%) Anticipation for strong clinical trial results and new drug candidates leading to analyst upgrades and target price hikes.
  
Most Critical Themes:
- Profit-Taking and Event Risk: (75%) Recent price dip suggests profit-taking and event-risk positioning ahead of near-term catalysts like Q3 results and clinical toplines.
  

### Top $pvla Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"8/ $PVLA This is a company with: No revenue No approved drugs High clinical risk High dilution risk High default risk A financing curve equivalent to distressed credit But trading like a high-certainty growth story"  
[X Link](https://x.com/Giulio01839130/status/1998493335099424774) [@Giulio01839130](/creator/x/Giulio01839130) 2025-12-09T20:41Z XXX followers, XX engagements


"1/ $PVLA is one of the clearest market mispricings in small-cap biotech this year. The stock trades at a $1B valuation despite generating $X revenue having no approved products and facing severe financial risk. A valuation built on storytelling not fundamentals"  
[X Link](https://x.com/Giulio01839130/status/1998492225873846681) [@Giulio01839130](/creator/x/Giulio01839130) 2025-12-09T20:37Z XXX followers, XX engagements


"$RGC $QMMM $ABVX $ZEPP $TOI $DFDV $NEGG $SUPX $RLMD $CDTX $XWIN $TII $PVLA $CELC $NBTX $ALM $IVVD $INBX $GRAL $TDUP $kala $drug $holo $mlgo $hkd 👇👇🔥🔥👇👇😎🔥"  
[X Link](https://x.com/Barryman833058/status/1998116365194977310) [@Barryman833058](/creator/x/Barryman833058) 2025-12-08T19:43Z XXX followers, XXX engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q4 2025 (1/2). $STOK Phase X $HRMY Phase X $RXRX Phase X $XCUR Phase X $IMMP Phase 2/3 $PVLA Phase X $LTRN Phase X $COGT Phase X $NKTR Phase 2b $RZLT Phase X $INSM Phase X $KMDA Phase X $MREO Phase X $RHHBY Phase X $TRAW Phase X $RARE Phase X $GPCR Phase 2b $ZBIO Phase X $SLS Phase X $MGTX Phase X $IDYA Phase 2/3 $DWTX Phase 2b $WVE Phase X $EWTX Phase X $ZYME Phase X $ZVSA Phase 2a $BHVN Phase X $VTYX Phase X $DBVT Phase X $VTGN Phase X $INBX Phase 2/3 $LSTA Phase 2a $ADVM Phase X $ALT Phase 2b $ACIU Phase X $RYTM Phase X $ATOS Phase 2"  
[X Link](https://x.com/BiopharmIQ/status/1997779928784519535) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-12-07T21:27Z 28.1K followers, 39.5K engagements